Pregnancy Outcomes in Infertile Patients After Treatment With Ulipristal Acetate.
NCT03533907 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20
Last updated 2018-06-08
Summary
The investigators analyzed a group of infertile women treated with Ulipristal Acetate (UA) for uterine fibroids at the Humanitas Fertility Center. All the patients' data were extracted from the Fertility Center external-audit-anonymized electronic research query system.
Conditions
- Myoma;Uterus
- Infertility, Female
Sponsors & Collaborators
-
Istituto Clinico Humanitas
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 45 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-11-01
- Primary Completion
- 2018-04-10
- Completion
- 2018-05-01
Countries
- Italy
Study Locations
More Related Trials
-
The Effect of Ulipristal Acetate (UPA) on Women Ovarian Reserve
NCT02361892 ·Status: UNKNOWN ·Phase: PHASE4
-
Ulipristal Acetate Versus GnRH Analogue and Myometrial Preservation
NCT02357563 ·Status: UNKNOWN ·Phase: PHASE4
-
Adenomyosis and Ulipristal Acetate
NCT02587000 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety Study of Ulipristal Acetate in Females With Anemia Associated With Uterine Leiomyoma
NCT01553123 ·Status: WITHDRAWN ·Phase: PHASE3
-
A Study of the Efficacy and Safety of a 3-month Treatment Course of Ulipristal Acetate for the Treatment of Abnormal Uterine Bleeding Associated With Leiomyomas
NCT02147197 ·Status: COMPLETED ·Phase: PHASE3
-
A Prospective Multicenter Non-interventional Study of Women Treated With ESMYA (Ulipristal Acetate) as Pre-operative Treatment of Moderate to Severe Symptoms of Uterine Fibroids
NCT01635452 ·Status: UNKNOWN
-
A Study of the Efficacy and Safety of Ulipristal Acetate Intermittent Treatment for Abnormal Uterine Bleeding Associated With Leiomyomas
NCT02147158 ·Status: COMPLETED ·Phase: PHASE3
-
Ulipristal Acetate for the Preoperative Management of Hypoechoic Cellular Leiomyomas
NCT02361905 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Ulipristal Acetate on Bleeding Patterns and Dysmenorrhea in Women With Adenomyosis
NCT03325868 ·Status: WITHDRAWN ·Phase: PHASE4
-
Ulipristal for Endometriosis-related Pelvic Pain
NCT02213081 ·Status: COMPLETED ·Phase: PHASE4
-
PGL4001 Efficacy Assessment in Reduction of Symptoms Due to Uterine Leiomyomata
NCT01642472 ·Status: COMPLETED ·Phase: PHASE3
-
Fertility After Myomectomy Versus Uterine Artery Embolization for Symptomatic Uterine Fibroids
NCT02577055 ·Status: COMPLETED ·Phase: NA
-
Endometriosis and Risk of Miscarriage
NCT03354780 ·Status: COMPLETED
-
Fertility After Uterine Artery Embolisation for the Treatment of Leiomyomas
NCT00839722 ·Status: COMPLETED ·Phase: PHASE2
-
Reproductive Outcome of EM Treated by GnRH-a Associated With Laparoscopy
NCT02779387 ·Status: UNKNOWN ·Phase: NA
-
Endometrial Injury in Women With Unexplained Infertility
NCT02628756 ·Status: COMPLETED ·Phase: NA
-
Effect of Endometrial Injury in Couples With Unexplained Infertility
NCT03398993 ·Status: UNKNOWN ·Phase: NA
-
Effect of Myomectomy for Intramural Myoma on Fertility Outcomes in Infertile Women
NCT03143114 ·Status: UNKNOWN ·Phase: NA
-
ExAblate Treatment of Uterine Fibroids for Fertility Enhancement
NCT00730886 ·Status: TERMINATED ·Phase: NA
-
Impact of Ultra-long Versus Long Down-regulation Protocol on IVF/ICSI in Adenomyosis
NCT03940807 ·Status: WITHDRAWN ·Phase: PHASE3
-
Fertility After Uterine Artery Embolization
NCT05271981 ·Status: COMPLETED
-
Fertility in Untreated Rectosigmoid Endometriosis
NCT04338035 ·Status: COMPLETED
-
Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
NCT00290251 ·Status: COMPLETED ·Phase: PHASE2
-
Endometrial Injury for Assisted Reproduction
NCT01132144 ·Status: TERMINATED ·Phase: PHASE3
-
Apical Pelvic Support in Infertility Patients
NCT04039009 ·Status: UNKNOWN